On May 15, AMCP joined dozens of other health care organizations in a sign-on letter thanking the Biden Administration for relaunching the Cancer Moonshot program. First launched in 2016 with the mission to accelerate the rate of progress against cancer, the program's national goal is to reduce the death rate of cancer by at least 50% over the next 25 years. The letter applauds the program's prioritization of cancer prevention, especially though human papillomavirus (HPV) vaccination.
AMCP's volunteers are vital players in propelling our mission forward. In this installment of the AMCP Volunteer Spotlight, we are featuring Matt Moen, PharmD, MBA, AMCP Membership Committee member.
On April 27, AMCP submitted comments in response to the Office of Management and Budget's Initial Proposals for Updating Race and Ethnicity Standards. In the comment letter, AMCP provides several recommendations which align with the organization's strategic priority of Addressing Disparities in Medication Use and Access.
A rapidly evolving area of interest is digital therapeutics, evidence-based software interventions used to treat, manage, or as an adjunct treatment for various medical conditions. Here are three reasons why you should attend the Virtual AMCP Summit: Deep Dive into Prescription Digital Therapeutics.
April 2023 Legislative & Regulatory Briefing: AMCP Statement on Federal Court Decisions Regarding FDA Approvals; AMCP Submits Comments on the Medicare Drug Price Negotiation Program; The Equitable Community Access to Pharmacist Services Act
is Reintroduced in Congress; AMCP Comments on Preventive Services Under the ACA; AMCP, Pharmacy Organizations Send Joint Request for Telehealth Prescribing of Buprenorphine.